Back to discover
Disease

Amphetamine-Related Disorders

Active therapeutic pipelineEmerging research
MeSHAmphetamine-Related Disorders
1
Publications
7
Clinical trials
2024
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 1 clinical trial expected to report results, the earliest in Q4 2026.
Upcoming Milestones
Major developments
Upcoming trial readoutImportant
Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder
Results expected Q4 20262026-04-22
Clinical Milestones1View
Results expected 1
Activity timeline1

Clinical trials

6 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
7
All trials
1
Active
0
Late-stage
6
Completed
Recently completed

Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM: a 6-month Randomized Controlled Trial With 3 Months of Follow-up

Phase 2 · Completed · Phillip Coffin, MD, MIA

Extended-Release Naltrexone (XR-NTX, VIVITROL) for the Treatment of Actively-Using Methamphetamine-Dependent Men Who Have Sex With Men

Phase 2 · Completed · San Francisco Department of Public Health

Mephedrone and Alcohol Interactions After Single-dose Administration in Humans

Phase 1 · Completed · Parc de Salut Mar

Biobehavioral Interventions for HIV-negative Methamphetamine-using MSM

Phase 2 · Completed · Friends Research Institute, Inc.

Bupropion for the Treatment of Methamphetamine Dependence

Phase 2 · Completed · National Institute on Drug Abuse (NIDA)

Double-Blind, Placebo-Controlled, Dose Response Trial of Ondansetron for the Treatment of Methamphetamine Dependence.

Phase 2 · Completed · National Institute on Drug Abuse (NIDA)

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Most influential

The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder.

Journal of addiction medicine · 2024 · 45 cites
Recent publications

The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder.

Journal of addiction medicine · 2024 · 45 cites
Major themes1
  • Central Nervous System Stimulants1
Leading journals1
  • Journal of addiction medicine1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Disorders related or resulting from use of amphetamines.

Identifiers
MeSHAmphetamine-Related Disorders
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.